These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9200313)

  • 1. Mediators of mucosal inflammation: implications for therapy.
    van Dullemen H; Meenan J; Stronkhorst A; Tytgat GN; van Deventer SJ
    Scand J Gastroenterol Suppl; 1997; 223():92-8. PubMed ID: 9200313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mediators of inflammation: production and implication in inflammatory bowel disease.
    Kolios G; Petoumenos C; Nakos A
    Hepatogastroenterology; 1998; 45(23):1601-9. PubMed ID: 9840114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review article: thromboxanes in inflammatory bowel disease--pathogenic and therapeutic implications.
    Rampton DS; Collins CE
    Aliment Pharmacol Ther; 1993 Aug; 7(4):357-67. PubMed ID: 8218751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory bowel disease. Current concepts of pathogenesis and implications for therapy.
    Fiocchi C
    Minerva Gastroenterol Dietol; 2002 Sep; 48(3):215-26. PubMed ID: 16491045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenic angiogenesis in IBD and experimental colitis: new ideas and therapeutic avenues.
    Chidlow JH; Shukla D; Grisham MB; Kevil CG
    Am J Physiol Gastrointest Liver Physiol; 2007 Jul; 293(1):G5-G18. PubMed ID: 17463183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune modulation and sepsis.
    Karzai W; Reinhart K
    Int J Clin Pract; 1997 Jun; 51(4):232-7. PubMed ID: 9287265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases.
    Calder PC
    Mol Nutr Food Res; 2008 Aug; 52(8):885-97. PubMed ID: 18504706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation and coagulation in inflammatory bowel disease: The clot thickens.
    Danese S; Papa A; Saibeni S; Repici A; Malesci A; Vecchi M
    Am J Gastroenterol; 2007 Jan; 102(1):174-86. PubMed ID: 17100967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding why probiotic therapies can be effective in treating IBD.
    Fedorak RN
    J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 1():S111-5. PubMed ID: 18806699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in biological therapy for inflammatory bowel disease.
    Kurtovic J; Segal I
    Trop Gastroenterol; 2004; 25(1):9-14. PubMed ID: 15303463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokines and inflammatory bowel disease.
    Anand AC; Adya CM
    Trop Gastroenterol; 1999; 20(3):97-106. PubMed ID: 10695414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune dysfunction in inflammatory bowel disease.
    Neuman MG
    Transl Res; 2007 Apr; 149(4):173-86. PubMed ID: 17383591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammation-associated immune suppression in cancer: the roles played by cytokines, chemokines and additional mediators.
    Ben-Baruch A
    Semin Cancer Biol; 2006 Feb; 16(1):38-52. PubMed ID: 16139507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current concept of the role of monocytes/macrophages in inflammatory bowel disease--balance of proinflammatory and immunosuppressive mediators.
    Lügering N; Kucharzik T; Stoll R; Domschke W
    Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):338-44. PubMed ID: 9759608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelets in inflammatory bowel disease: clinical, pathogenic, and therapeutic implications.
    Danese S; Motte Cd Cde L; Fiocchi C
    Am J Gastroenterol; 2004 May; 99(5):938-45. PubMed ID: 15128364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory bowel disorders: gene therapy solutions.
    Wirtz S; Neurath MF
    Curr Opin Mol Ther; 2003 Oct; 5(5):495-502. PubMed ID: 14601518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Leptin and chronic inflammatory bowel disease: the human labyrinth].
    Reimund JM
    Gastroenterol Clin Biol; 2003 Nov; 27(11):983-5. PubMed ID: 14732843
    [No Abstract]   [Full Text] [Related]  

  • 18. Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases.
    Sartor RB
    Am J Gastroenterol; 1997 Dec; 92(12 Suppl):5S-11S. PubMed ID: 9395346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of inflammatory cytokines by omega-3 fatty acids.
    Kang JX; Weylandt KH
    Subcell Biochem; 2008; 49():133-43. PubMed ID: 18751910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of animal models for the pathogenesis and treatment of inflammatory bowel disease.
    Dieleman LA; Peña AS; Meuwissen SG; van Rees EP
    Scand J Gastroenterol Suppl; 1997; 223():99-104. PubMed ID: 9200314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.